Agility: How Pharma Can Be Bolder, Faster, Better

Agility is the watchword of our age.

In a volatile, uncertain, complex and ambiguous world, where competition is fierce for customers who have more power than ever, the ability to respond rapidly to market changes without betting the future of the organization on getting such responses right will define survival.

Insights from eyeforpharma’s latest white paper include:

  • Why agility matters
  • How Agile is pharma?
  • Agile starts with the customer
  • Start small, fail fast
  • Measuring your Agility

Agility: How Pharma Can Be Bolder, Faster, Better includes insights from across the industry through interviews with the senior leaders of Pfizer, AstraZeneca, Agility in Mind, W20 group and McKinsey & Co.

Please subscribe to view the analysis report